BioStack Platforms
PrivateLast Round
Seed
Oct 22, 2026
Total Funding Raised
$10M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
BioStack Platforms operates in AI, Data & Cloud Infrastructure and is based in San Francisco, California. Its latest recorded funding round was a Seed round in October 2026.
BioStack Platforms is a healthcare technology company that provides a data engine with high-quality biological data and training environments for AI models in healthcare and drug discovery.
Sector
AI, Data & Cloud Infrastructure
Verticals
AI Training Infrastructure, Drug Discovery, Synthetic Data, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioStack Platforms Comparables
Compare BioStack Platforms with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeraScope Inc. | 85% | |
| Dandelion Health | 80% | |
| Syntegra | 74% |
For institutional investors. Book with your work email.
BioStack Platforms Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 22, 2026 | ||||
| Seed | Jun 1, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioStack Platforms Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Angel | Seed |
| Lobster Capital | Seed |
| Peak XV Partners | Seed |
| Streamlined Ventures | Seed |
| Afore Capital | Seed |
| Emerson Collective | Seed |
| Y Combinator | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$10M round with DCVC and Emerson Collective.
- Jun 1, 2026
$500K raised from Afore Capital, Heroic Ventures, and others.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 26, 2026
BioStack receives $9.5M in Seed financing led by Peak XV, Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, and Y Combinator on Oct 22nd '26 in California to support its U.S. and international expansion, technology platform, and engineering and research teams.
- launchesOct 22, 2026
BioStack launches a data infrastructure network to power the next era of medicine, connecting more than 100 million de-identified patient records across the United States, India, Brazil, and Argentina, in California on Oct 22nd '26.
For institutional investors. Book with your work email.
BioStack Platforms Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioStack Platforms's valuation, stock price, and market status.
Is BioStack Platforms a public or private company?
BioStack Platforms is a private company.
What is the current stock price of BioStack Platforms?
BioStack Platforms is a private company, so its shares have no public market price. Caplight tracks BioStack Platforms's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioStack Platforms worth (valuation)?
Valuation information for BioStack Platforms is not publicly available.
Can I buy BioStack Platforms stock?
BioStack Platforms shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioStack Platforms's last funding round?
BioStack Platforms's most recent funding round was Seed on October 22, 2026.
Who are the main investors in BioStack Platforms?
Key investors in BioStack Platforms include Peak XV Partners.
Will BioStack Platforms IPO soon?
No public IPO plans have been announced for BioStack Platforms.
How can I track BioStack Platforms secondary market activity?
Caplight tracks bids, offers, and trades in BioStack Platforms's shares on secondary markets.